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Abstract: Mycotoxins are emerging toxins in the marine environment, which can co-occur with
algal toxins to exert synergistic or antagonistic effects for human seafood consumption. The current
study assesses the cytotoxicity of the algal toxin okadaic acid, shellfish, and dust storm-associated
mycotoxins alone or in combination on human intestinal (HT-29) and neuroblastoma (SH-SY5Y)
cell lines. Based on calculated IC50 (inhibitory concentration 50%) values, mycotoxins and the
algal toxin on their own exhibited increased cytotoxicity in the order of sydowinin A < sydowinin
B << patulin < alamethicin < sydowinol << gliotoxin ≈ okadaic acid against the HT-29 cell line, and
sydowinin B < sydowinin A << alamethicin ≈ sydowinol < patulin, << gliotoxin < okadaic acid
against the SH-SY5Y cell line. Combinations of okadaic acid–sydowinin A, –alamethicin, –patulin, and
–gliotoxin exhibited antagonistic effects at low-moderate cytotoxicity, but became synergistic at high
cytotoxicity, while okadaic acid–sydowinol displayed an antagonistic relationship against HT-29 cells.
Furthermore, only okadaic acid–sydowinin A showed synergism, while okadaic acid–sydowinol,
–alamethicin, –patulin, and –gliotoxin combinations demonstrated antagonism against SH-SY5Y.
While diarrhetic shellfish poisoning (DSP) from okadaic acid and analogues in many parts of the
world is considered to be a comparatively minor seafood toxin syndrome, our human cell model
studies suggest that synergisms with certain mycotoxins may aggravate human health impacts,
depending on the concentrations. These findings highlight the issues of the shortcomings of current
regulatory approaches, which do not regulate for mycotoxins in shellfish and treat seafood toxins as
if they occur as single toxins.
Keywords: okadaic acid; sydowinin A; sydowinol; alamethicin; patulin; gliotoxin; combination
index; synergy
Key Contribution: The present study, using human intestinal (HT-29) and neuroblastoma (SH-SY5Y)
cell line models, demonstrated that okadaic acid–shellfish and –dust storm-associated mycotoxin
combinations can result in synergistic toxic effects.
1. Introduction
The importance of fungi in the marine environment has been increasingly recognised in recent
years. They are capable of infecting a wide range of marine animals, including sea turtles [1] and sea
fan corals [2], and threatening human health through mycotoxin accumulation in seafood [3]. The
majority of infectious fungi in the marine environment are considered to be of terrestrial origin [4],
but atmospheric dust deposition and terrestrial runoff can facilitate the growth of fungi already
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residing in the marine environment and/or introduce them from terrestrial into marine environments.
For example, an Aspergillus sydowii “bloom” (150,000 spores/m2) along the east coast of Australia was
observed after an extensive dust storm in 2009 [5]. Similarly, increased dust deposition and nutrient
input from terrestrial runoff is thought to have contributed to an outbreak of the fungal disease sea fan
coral aspergillosis in the Caribbean [6].
Fungal contaminants in seafood can also pose a significant human health risk. Several studies
have shown that toxigenic fungal species can reside within the shellfish itself, seawater, and
sediments from aquaculture farming areas. Penicillium, Aspergillus, Trichoderma, and Cladosporium
have been isolated from such samples in France [7], Canada [8], Algeria [9], Russia [10], Brazil [11],
Italy [12], and Tunisia [13]. These genera of fungi are capable of producing toxic metabolites
(mycotoxins), including aflatoxins (AF), zearalenone (ZEA), deoxynivalenol (DON), fumonisins (FB),
and ochratoxins (OTA) [14]. These compounds exhibit a wide range of biological activities, including
hepatocarcinogenic, genotoxic, carcinogenic, oestrogenic, nephrotoxic, and nephrocarcinogenic
effects [15]. Evidence exists that some shellfish-associated fungal isolates were capable of producing
highly toxic mycotoxins, such as gliotoxin by Aspergillus fumigatus [3], patulin by Penicillium sp. [16],
peptaibol by Trichoderma sp. [17], and griseofulvin by P. waksmanii [18]. These mycotoxins have
been demonstrated to bio-accumulate in shellfish under both laboratory and natural conditions.
A filtrate of marine-derived T. koningii, gliotoxin accumulated in shellfish, and peptaibols were detected
in shellfish and sediments from aquaculture environments [3,17,19]. C17-sphinganine analogue
mycotoxin (C17-SAMT) was claimed to be solely responsible for high shellfish toxicity in Tunisia in
2006 [13]. Mycotoxins are now widely viewed as new emerging toxins in shellfish.
Mycotoxins on their own can pose a significant health risk for humans through shellfish
consumption, but an even greater concern arises from their possible synergistic effects with
co-occurring algal toxins. However, mycotoxins in shellfish are currently not monitored and
information on the combined effects of algal toxins and mycotoxins is sparse. So far, an in vivo
Diptera larval bioassay by Ruiz et al. has been the only study to assess the combined effects of the
algal toxin domoic acid and mycotoxin. Their study revealed increased toxicity by up to 34.5 times
(the synergism factor) when domoic acid and longibranchi-A-I were injected together into Diptera
larvae [20]. The proposed mechanism of this synergism was enhanced by an increase in Ca2+ influx
into the cells by both domoic acid and novel peptaibol longibranchi-A-I [20].
The management of seafood safety is important for public health, market access, and public
confidence. For example, a single incident of failure of detecting unacceptable levels of paralytic
shellfish toxins (PST) in exported mussels resulted in AUD$24 million dollar economic loss to the
Tasmanian seafood industry [21]. Current approaches to seafood safety management do not regulate
for mycotoxins, and take no account of combined effects of co-occurring seafood toxins and treat them
as if they were to occur as individual compounds [22,23]. Therefore, the aim of this study was to
identify the toxic interactions of major algal toxins (e.g., saxitoxin, domoic acid and okadaic acid) and
shellfish-associated (e.g., gliotoxins, patulin and peptaibol) and dust-originated (A. sydowii metabolites
and sterigmatocystin [24]) mycotoxins (Figure 1) using human intestinal HT-29 and neuroblastoma
SH-SY5Y cell line models. HT-29 and SH-SY5Y were chosen for assessing gastrointestinal and
neurological effects, respectively, from saxitoxin [25], domoic acid [26] and okadaic acid [27]. Toxin
interactions such as synergisms, antagonism, and additive were quantitatively evaluated with the
combination index (CI) method [28].
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Figure 1. Chemical structures of typical algal toxins (okadaic acid, saxitoxin, domoic acid), dust storm-
related mycotoxins (major A. sydowii metabolites and sterigmatocystin), and shellfish-related 
mycotoxins (patulin, alamethicin, gliotoxin). 
2. Results 
2.1. Individual Cytotoxicity of Algal Toxin and Mycotoxin 
The cytotoxicity of individual mycotoxins and phycotoxins on the human intestinal cell line HT-
29 and human neuroblastoma cell line SH-SY5Y was evaluated using resazurine cell viability reagent. 
The tested mycotoxins, except sydowic acid, exhibited a dose-dependent effect with a range of 
inhibitory concentration 50% (IC50) from 65 nM to 124 µM for HT-29, and from 45 nM to 144 µM for 
SH-SY5Y (Table 1 and Supplementary Data in Figures S1 and S2). The tested concentration ranges of 
sydowic acid (HT-29: 0.028–283.75 µM, SH-SY5Y: 0.567–567.49 µM) showed no significant effect on 
viability for both HT-29 and SH-SY5Y (HT-29: F(8,27) = 0.095, p = 0.999, SH-SY5Y: F(4,15) = 1.516, p = 
0.248). Sterigmatocystin reduced the viability of both HT-29 and SH-SY5Y in a dose-dependent 
manner with an incomplete sigmoid curve. The highest applicable concentration of 62 and 123 µM 
sterigmatocystin lowered the viability of HT-29 to 60%, and that of SH-SY5Y to 43%, respectively. 
Therefore, the IC50 of sterigmatocystin was not calculated. Okadaic acid displayed a dose-dependent 
effect on HT-29, with IC50 of 65 nM, and SH-SY5Y viability, with IC50 of 27 nM, whereas the other 
tested algal toxin, saxitoxin, and domoic acid had either no effect or minor effects on the viability of 
HT-29 and SH-SY5Y (maximum tested concentrations were 16.6–1.33 µM) (Figures S1,S2). For the 
overall cytotoxicity ranking, based on the calculated IC50 values, the tested mycotoxin and algal toxin 
 
Figure 1. Chemical structures of typical algal toxins (okadaic acid, saxitoxin, domoic acid), dust
storm-related mycotoxins (major A. sydowii metabolites and sterigmatocystin), and shellfish-related
mycotoxins (patulin, alamethicin, gliotoxin).
2. Results
2.1. Individual Cytotoxicity of Algal Toxin and Mycotoxin
The cytotoxicity of individual mycotoxins and phycotoxins on the human intestinal cell line HT-29
and human neuroblastoma cell line SH-SY5Y w s evaluated using resazurine cell viability reagent. The
teste mycotoxins, except sydowic acid, exhibited a dose-dependent effect with a range of inhibitory
conc ntration 50% (IC50) from 65 nM to 124 µM for HT-29, and from 45 nM to 144 µM for SH-SY5Y
(Ta le 1 and Supplementary Data in Figures S1 and S2). The tested concentration ranges of sydowic
acid (HT-29: 0.028–283.75 µM, SH-SY5Y: 0.567–567.49 µM) showed no significant effect on viability
for both HT-29 and SH-SY5Y (HT-29: F(8,27) = 0.09 , p = 0.999, SH-SY5Y: F(4,15) = 1.516, p = 0.248).
Sterigmatocystin reduced the viability of both HT-29 and SH-SY5Y in a dose-dependent manner with
an incomplete sigmoid curve. The highest applicable concentratio of 62 and 123 µM sterigmatocystin
lowered the viability of HT-29 to 60%, and that of SH-SY5Y to 43%, respectively. Therefore, the IC50
of sterigmatocystin was not calculated. Okadaic acid displayed a dose-dependent effect on HT-29,
with IC50 of 65 nM, and SH-SY5Y viability, with IC50 of 27 nM, whereas the other tested algal toxin,
saxitoxin, and domoic acid had either no effect or minor effects on the viability of HT-29 and SH-SY5Y
(maximum tested concentrations were 16.6–1.33 µM) (Figures S1 and S2). For the overall cytotoxicity
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ranking, based on the calculated IC50 values, the tested mycotoxin and algal toxin were found to be in
the increasing order of sydowinin A < sydowinin B << patulin < alamethicin < sydowinol << gliotoxin
≈ okadaic acid in HT-29, and sydowinin B < sydowinin A << alamethicin ≈ sydowinol < patulin,
<<gliotoxin < okadaic acid in SH-SY5Y.
Table 1. Summary of cytotoxicity of typical A. sydowii metabolites, dust storm/shellfish-associated
mycotoxins, okadaic acid algal toxins on HT-29 and SH-SY5Y cells after 24 h exposure. Inhibitory
concentration 50% (IC50) values and 95% confidence interval (CI) were calculated from four replicates
using the four-parameter logistic model (4PL) model.
Toxin
HT-29
95% CI
SH-SY5Y
95% CI
IC50 (µM) IC50 (µM)
Typical A. sydowii metabolites
Sydowinin A 124.30 113.60–136.00 117.80 105.60–131.40
Sydowinin B 93.06 82.20–105.40 143.8 116.00–178.20
Sydowinol 2.50 2.21–2.82 5.14 5.06–5.23
Sydowic acid NE (283.75) 1 - NE (283.75) 1 -
Dust storm/shellfish mycotoxins
Sterigmatocystin >61.67 2 - ~123.35 2 -
Patulin 17.46 10.79–28.28 2.23 2.15–2.32
Alamethicin 4.92 4.57–5.29 5.43 5.29–5.67
Gliotoxin 0.062 0.052–0.075 0.045 0.039–0.053
Algal toxins
Okadaic acid 0.065 0.056–0.075 0.027 0.026–0.029
1 NE indicates toxins had no significant effect within the tested concentration range. Numbers in brackets indicate
the maximum applicable concentration tested. 2 The maximum applicable concentration of 61.67 µM and 123.35 µM
sterigmatocystin lowered the viability to 60% on HT-29 and 43% on SH-SY5Y, respectively.
2.2. Combined Cytotoxicity of Mycotoxins and Algal Toxin
Since okadaic acid was the only algal toxin which exhibited cytotoxicity on both HT-29 and
SH-SY5Y cells, the effects of combined okadaic acid and mycotoxin sydowinin A, sydowinol, patulin,
alamethicin, and gliotoxin on cell viability of HT-29 and SH-SY5Y were examined. Sydowinin B,
sydowic acid, and sterigmatocystin were eliminated from the combined cytotoxicity assay because
of their low cytotoxicity and limited solubility. Furthermore, the combination ratios were chosen to
have an equipotent toxicity of each toxin (e.g., (IC50)1/(IC50)2 ratio) (Table 2), as there were no data
available on the concentration of mycotoxins in shellfish, and this was recommended by Chou for
an early stage study [29]. The combination index (CI) values were calculated from a fraction of cell
viability affected (fa) values of 0.05 (corresponding to IC05) to 0.97 (corresponding to IC97), and the
dose reduction index (DRI) was calculated when synergistic interactions were detected. All the binary
mixtures of toxins showed a dose-dependent effect on HT-29 and SH-SY5Y cells (Figures S3 and S4).
Table 2. Molar combination ratio of okadaic acid and mycotoxin mixtures used in the assay.
Toxin Mixture
Molar Combination Ratio
HT-29 SH-SY5Y
Okadaic acid:Sydowinin A 1:1925.0 1:14366.2
Okadaic acid:Sydowinol 1:38.7 1:190.7
Okadaic acid:Alamethicin 1:76.6 1:201.1
Okadaic acid:Patulin 1:270.4 1:82.6
Okadaic acid:Gliotoxin 1:1.04 1:1.68
2.3. Okadaic Acid and Mycotoxins on Human Intestinal HT-29 Cells
Okadaic acid–sydowinin A, –alamethicin, –patulin, and –gliotoxin binary mixtures displayed
variations of the interaction types on human intestinal HT-29 cells dependent upon the effect levels
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(Figure 2). At low to moderate effect levels (fa < 0.65), these combinations exhibited antagonistic
to additive effects, while they presented synergistic relationships at higher effect levels (fa > 0.65).
In contrast to these okadaic acid–mycotoxin mixtures, okadaic acid–sydowinol mixtures displayed
antagonistic effects at fa > 0.95 and a nearly additive interaction at fa < 0.95 (Figure 2). The DRI values
for okadaic acid and mycotoxins varied from 1.8 to 12.5 and 1.8 to 12.2, respectively (Table 3). The
greatest synergistic effect at fa = 0.9 was noted for the binary mixture of okadaic acid and gliotoxin, with
a CI value of 0.41. For this combination, at the effect level of 0.9, the okadaic acid and gliotoxin mixture
was 12.4 times more potent than okadaic acid alone, and 3 times more effective than gliotoxin alone.Toxins 2018, 10, x FOR PEER REVIEW  6 of 15 
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Table 3. Combination index (CI) and dose reduction index (DRI) values for okadaic acid and mycotoxin
combinations in HT-29 and SH-SY5Y cells at various effect levels (IC25, IC50, IC75 and IC90). DRI values
were only calculated when synergistic effects were detected. DRI implies fold of dose reduction for a
given effect in a combination of toxins compared with the dose of each toxin alone.
Toxin Mixture
CI at DRI at
IC25 IC50 IC75 IC90 IC25 IC50 IC75 IC90
HT-29
Okadaic acid 1.67 1.24 0.93 0.69 - - 2.72 3.61
Sydowinin A - - 1.80 2.43
Okadaic acid 1.47 1.34 1.23 1.13 - - - -
Sydowinol - - - -
Okadaic acid 1.06 0.88 0.78 0.72 - 2.41 2.18 1.98
Alamethicin - 2.14 3.14 4.61
Okadaic acid 1.53 1.01 0.75 0.53 - - 1.76 1.95
Patulin - - 5.63 12.23
Okadaic acid 2.84 1.42 0.75 0.41 - - 4.80 12.45
Gliotoxin - - 1.85 3.02
SH-SY5Y
Okadaic acid 0.72 0.69 0.67 0.65 2.98 3.09 3.20 3.32
Sydowinin A 2.65 2.72 2.79 2.86
Okadaic acid 1.34 1.33 1.34 1.34 - - - -
Sydowinol - - - -
Okadaic acid 1.30 1.33 1.36 1.41 - - - -
Alamethicin - - - -
Okadaic acid 1.29 1.30 1.32 1.34 - - - -
Patulin - - - -
Okadaic acid 1.30 1.48 1.68 1.91 - - - -
Gliotoxin - - - -
2.4. Okadaic Acid and Mycotoxins on Human Neuroblastoma SH-SY5Y Cells
Okadaic acid–sydowinol, –alamethicin, –patulin, and –gliotoxin mixtures on human
neuroblastoma SH-SY5Y cells showed an antagonistic interaction type at all effect levels, except that at
fa = 0.05; gliotoxin and okadaic acid exhibited an additive interaction type (Figure 3). The calculated CI
values for these combinations varied from 1.15 to 2.21 (Figure 3). By contrast, okadaic acid–sydowinin
A mixtures exhibited synergisms at all effect levels, with a CI of 0.65 at fa = 0.9. For this combination,
at the effect level of 0.9, the okadaic acid and sydowinin A mixture was 3.3 times more effective than
okadaic acid alone and 2.9 times more effective than sydowinin A alone (Table 3).
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Figure 3. Combination index (CI)–fraction affected (fa, indicating fraction of cell viability affected.
fa = 0.05–0.97 corresponds to 5–97% toxicity) curves for binary mixtures of okadaic acid and sydowinol,
sydowinin A, alamethicin, patulin, and gliotoxin against human neuroblastoma SH-SY5Y cells. CI < 1,
CI = 1, and CI > 1 indicate synergistic (orange rectangle), additive (red line), and antagonistic (blue
rectangle) effects of binary mixtures, respectively. The error bar indicates 95% confidence intervals
calculated using sequential deletion analysis (SDA).
3. Discussion
We demonstrated in this study that binary mixtures of the phycotoxin okadaic acid, and dust-
and shellfish-associated mycotoxins exhibited cell line- and concentration-dependent antagonistic
or synergistic interactions. Combinations of okadaic acid–sydowinin A, –alamethicin, –patulin, and
–gliotoxin exhibited synergisms at higher effect levels and antagonisms at lower effect levels on HT-29.
Interestingly, only okadaic acid–sydowinin A displayed synergism, whereas antagonism was noted
for other combinations on SH-SY5Y at all effect levels. DRI values indicated that toxin doses can
be theoretically reduced by up to 1.8 to 12-fold for the combination to have the same effect as that
induced by each toxin on its own. These findings suggested that ingestion of a regulatory safe level
of the algal toxin okadaic acid (0.16 mg OA eq./kg) could result in a health impact due to synergism
with mycotoxin.
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3.1. Synergisms between Okadaic Acid and Mycotoxins
We speculate that synergistic effects of okadaic acid and the tested mycotoxins on HT-29 could
be the result of the impairment of cell structure. Okadaic acid is the main lipophilic marine biotoxin
produced by Dinophysis and Prorocentrum dinoflagellates and responsible for diarrhetic shellfish
poisoning (DSP) in humans [30]. Okadaic acid is an inhibitor of serine/threonine protein phosphatases
(PP), which affect various important cellular metabolic processes, leading to cytoskeleton and intestinal
mucosa deterioration, digestive dysfunction, lipid metabolism disorders, oxidative stress, and cellular
apoptosis [31]. These series of events contribute to the gut barrier impairment and intestinal cell
degeneration, which results in human diarrheic symptoms [31]. The mycotoxin alamethicin, also
known as peptaibol, forms pores in membranes, thereby increasing membrane permeability [32].
Similarly, gliotoxin specifically binds to cytoplasmic membrane thiol groups, causing an increase
in membrane permeability by affecting membrane protein orientation [33]. Patulin also induces
the depletion of nonprotein sulfhydryl groups and increases potassium efflux, which results in
the loss of structural integrity of the plasma membrane [34]. While mycotoxins have different
mechanisms of action, they all lead to a disruption of ion homeostasis and structural damage which
in turn potentially compounds downstream effects caused by okadaic acid in particular cytoskeleton
deterioration, oxidative stress, and apoptosis. Furthermore, the observed shifts from antagonism to
additive/synergism with increasing concentrations in the current study have also been reported in the
similar study, where the interaction types of lipophilic phycotoxins (e.g., okadaic acid, pectenetoxin-2,
yessotoxin, spirolide-1) were examined [35].
Okadaic acid and sydowinin A exhibited synergistic effects on both the HT-29 and SH-SY5Y
cell lines. Currently, we lack knowledge of the details of the mode of action of the major Aspergillus
sydowii metabolites sydowinin A and sydowinol. Sydowinin A has been reported to have more potent
immunosuppressive effects on the Con A-induced and lipopolysaccharide-induced proliferations
of mouse splenic lymphocytes compared to other A. sydowii metabolites [36]. The current study
and other studies supported evidence of that the okadaic acid-induced PP inhibition also induces
various neurotoxic effects [37,38]. However, no major human neurotoxic symptoms from ingesting
okadaic acid-contaminated seafood have been reported so far, probably due to the levels of okadaic
acid accumulating more slowly in the brain compared to the stomach and gastrointestinal tract
tissues [39]. Synergistic relationships between okadaic acid and sydowinin A may have a basis in that
the immunosuppressive characteristics of sydowinin A could sensitise cells to okadaic acid, but this
requires investigation. The observed synergistic relationships with sydowinin A imply that even a low
level of okadaic acid may cause significant neurotoxic effects in humans.
3.2. Antagonisms between Okadaic Acid and Mycotoxin on SH-SY5Y
The combination of okadaic acid and the tested mycotoxins exhibited antagonistic relationships
against SH-SY5Y neuroblastoma cells, whereas interactions were synergistic against HT-29 intestinal
cell lines. Antagonistic interactions were also noted for HT-29 at the low effect level. These observed
antagonisms could be explained by multidrug resistance (MDR). MDR is regulated by P-glycoprotein
(P-gp), which functions as an efflux transport pump, removing toxins from the plasma membrane,
hence reducing cytotoxicity [40]. Okadaic acid efflux occurred in okadaic acid-resistant Chinese
hamster ovary cells with increased levels of P-gp [41]. Therefore, the observed antagonisms in
SH-SY5Y cells could be related to less mycotoxin binding to the target site, while okadaic acid is
actively removed from the plasma membrane. This could lead to lower toxicity than estimated for the
combined effect. This is supported by the fact that undifferentiated SH-SY5Y cells expressed some
degree of P-gp expression, while HT-29 showed no detectable P-gp [42,43]. Furthermore, in the present
study, mycotoxins were more abundant than okadaic acid in the binary mixtures, which could make
mycotoxins more readily bind to the target site. Similarly, Alassane-Kpembi et al. (2015) suggested
that the MDR drug efflux mechanism might explain the observed antagonism between deoxynivalenol
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(DON)–3-Acetyldeoxynivalenol (3-ADON) and DON–Fusarenon-X (FX) combinations [44]. However,
the suggested mechanisms of antagonisms remain speculative and require further study.
4. Conclusions
The present study demonstrated that binary mixtures of okadaic acid and shellfish- and
dust-associated mycotoxins displayed cell line- and concentration-dependent interactions. The general
interaction patterns observed in this study were a shift from antagonism to synergism with increasing
concentrations on HT-29 cells, and antagonism or synergism at all concentrations on SH-SY5Y cells.
The synergistic effects observed in the current study are of practical significance. While diarrhetic
shellfish poisoning from okadaic acid and analogues is widely considered to be a comparatively minor
seafood toxin syndrome (e.g., no human fatalities have ever occurred), our human cell model studies
provided preliminary insights that synergisms with mycotoxins can be expected to more seriously
aggravate human health impacts.
This also suggests the need for implementing more studies of seafood where there is risk of
the co-occurrence of mycotoxins and algal toxins. Our results clearly demonstrate that the toxin
interaction type depends on the effect level and cell type. This points to difficulties of predicting toxin
interactions from the known mechanisms of actions of individual toxins without actual experimental
data [29]. Mycotoxins are emerging toxins in seafood, and their occurrence may increase due to
increased terrestrial runoff, dust storms, and the use of mycotoxin contaminated aquaculture feeds [23].
The current study did not explore the precise cellular mechanisms behind the mycotoxin and algal
toxin interaction, and suggested mechanisms therefore remain speculative, and deserve further study.
Future work should prioritise determining the interaction types of commonly occurring algal toxins
(e.g., saxitoxin and domoic acid), and other mycotoxins (e.g., DON, AF, ZEA, FB, and OTA) [45].
Multiple mixtures (e.g., more than two toxins) should also be considered. Our results highlight the
possible risks of toxin co-occurrence in seafood, a scenario which is not considered in current shellfish
safety regulations.
5. Materials and Methods
5.1. Cell Line Cultures
Human neuroblastoma SH-SY5Y was kindly provided by Ms Yilan Zhen and Dr. Kaylene
Young (Menzies Institute for Medical Research, University of Tasmania, Australia). Human colorectal
adenocarcinoma cells HT-29 were kindly provided by Dr. Anthony Baker (Tasmanian Institute
of Agriculture, University of Tasmania and School of Land and Food, Australia). Both cell lines
were routinely maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, D0819, Sigma-Aldrich,
Sydney, Australia) supplemented with 10% foetal bovine serum (FBS, Bovogen Biologicals, Melbourne,
Australia), and 100 U/mL penicillin and 100 mg/mL streptomycin solution in a humidified incubator
(5% CO2, 37 ◦C). SH-SY5Y cells were routinely subcultured at a ratio of 1:30–1:50, and medium
changeover occurred approximately every 5 d. HT-29 cells were routinely subcultured at a ratio of
1:3–1:8, and medium changeover occurred approximately every 4 d.
5.2. Mycotoxin and Phycotoxin Toxins
Four typical Aspergillus sydowii metabolite standards, sydowinin A, sydowinin B, sydowinol,
and sydowic acid were kindly provided by Professor Hiromitsu Nakajima, Tottori University, Japan.
These compounds were isolated from A. sydowii IFO 4284 and IFO 7531 strains. Full descriptions
of UV, IR, and NMR spectra, chemical structures, and molecular weights of these metabolites were
previously provided by Hamasaki et al. (1975a,b) [46,47]. The crystallised A. sydowii metabolites were
weighted on a microbalance and dissolved in small volumes of acetone (>0.5 mL). Among the other
fungal toxins tested, gliotoxin (G9893, Sigma-Aldrich) was dissolved in ethanol, alamethicin (A4665,
Sigma-Aldrich) was dissolved in DMSO, and sterigmatocystin (S3255, Sigma-Aldrich) and patulin
Toxins 2018, 10, 526 10 of 14
(P1639, Sigma-Aldrich) were dissolved in acetonitrile. Phycotoxin standards, saxitoxin (CRM-STX-f),
domoic acid (CRM-DA-g), and okadaic acid (CRM-OA-d) were purchased from the National Research
Council Canada. Concentrations used are expressed as µM.
5.3. Cytotoxicity Bioassays
When cells reached >70% confluency, they were detached using a trypsin–EDTA solution.
Detached cells were centrifuged 300 g for 5 min and resuspended. Cells were seeded to a 96-well plate
at 1.0 × 104 cells/well for HT-29 and 3.0 × 104 cells/well for SH-SY5Y and allowed to attach for 24 h
prior to toxin exposure. Each well contained 100 µL of cells suspension, and 0.5–3% (v/v) of algal toxin
and mycotoxins stocks were added to the basal DMEM, which contained no supplemented FBS nor
antibiotics. Concentration ranges of tested individual toxicity of algal toxins and mycotoxins were
1.33× 10−9–123.3 µM for SH-SY5Y, and 3.12× 10−8–235.6 µM for HT-29. For the combined cytotoxicity
bioassay, the ranges were 0.019–214.9 µM for HT-29 and 0.016–169.6 µM for SH-SY5Y. Cells were
rinsed once with DPBS (Dulbecco’s phosphate-buffered saline, 0.9 mM CaCl2; 0.50 mM MgCl2·6H2O;
2.7 mM KCl; 1.5 mM KH2PO4; 137.9 mM NaCl; 8.1 mM Na2HPO4·7H2O). Toxin-containing DMEM
was added to each well and incubated further for 24 h. Controls received only solvents, and the
solvent concentration used in the assay was preliminary tested to have no significant effect on the
cell viability compared to those received basal DMEM without solvents (data not shown). After toxin
exposure, the cells were washed once again with DPBS and 100 µL of the same basal media (without
phenol red) containing 5% resazurin solution [48] were added to each well. Following additional 2 h
incubation in the dark, the plate was read with a BMG FLUOstar OMEGA plate reader using excitation
of 540 nm and emission of 590 nm. Cell viability was expressed as the percentage of fluorescence
reading compared to the control (% of control). Four replicates were prepared for each treatment.
5.4. Statistical Analysis of Cytotoxicity of Individual Mycotoxin and Algal Toxin
Data analysis was conducted with the decision tree proposed by Sérandour et al. [49], except
that in this experiment, the controls were preliminary tested to have no effect on cell viability and no
further calculation was conducted when there was no bottom asymptote. Briefly, the dose response
curves were fitted with the four-parameter logistic model (4PL), and 95% asymptotic confidence
intervals were calculated using GraphPad Prism 7. The half-maximal inhibitory concentration (IC50)
indicating the concentration that caused a half-maximal viability was calculated for each toxin. IC50
was accepted if the fitting dose–response curve had R2 > 0.85 and standard of error of log IC50 was
<40%. One-way analysis of variance (ANOVA) was used to evaluate statistical differences between
control and treatments. Tukey’s honestly significant different (HSD) post hoc tests were performed
when the main effect was significant. Appropriate data transformation was determined using Box–Cox
transformation. ANOVA and follow-up statistical analyses were performed with the statistical software
R (R Development Core Team, version 3.4.3) [50]. A significance level of 0.05 was applied in this study.
5.5. Median Effect and Combination Index Analysis of Mycotoxin and Algal Toxin Mixture
The cytotoxicity of mycotoxin and algal toxin mixture was analysed based on the Chou–Talalay
method [28]. The combination of mycotoxin and algal toxin were at an equipotency ratio (e.g.,
(IC50)1/(IC50)2 ratio) based on the calculated IC50 values using the graphpad prism 4PL model;
therefore, each toxin roughly affects the cell viability equally [29]. The dose–responses for individual
toxins and their mixture were modelled using the median effect equation of the mass action law:
f a
f u
=
(
D
Dm
)m
(1)
where D is the dose of the toxin, Dm is the median effect dose (e.g., IC50), fa is the fraction affected by
dose (D) (e.g., fractions of cell viability affected), fu represents the fraction unaffected, and m indicates
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the shape of the slope (m = 1, > 1, and < 1 indicate hyperbolic, sigmoidal, and flat sigmoidal curves,
respectively). Toxin interactions were only analysed when the linear correlation coefficient (r) of the
median effect plot was greater than 0.92.
The mycotoxin and algal toxins interaction was analysed by the combination index (CI) method
derived from the median effect equation of the mass action law. The combination index was calculated
using the following equation below [29]:
n(CI)x =
n
∑
j=1
(D)j
(Dx)j
(2)
where n(CI)x is the combination index for n mycotoxins and algal toxins that inhibits x percent of
a system (e.g., viability), (D)j are the doses that mixture of n phyco- and mycotoxins that inhibits x
percent of a system, and (Dx)j are the doses that each phyco- and mycotoxin itself inhibits x percent of
a system. CI < 1, = 1, and > 1 indicate synergism, additive effect, or antagonism, respectively. CI values
were calculated over a range of fa = 0.05 to 0.97 (5–97% toxicity). A confidence interval of 95% (95% CI)
for CI was calculated based on sequential deletion analysis (SDA). The dose reduction index (DRI)
values were determined for the combination that exhibited a synergistic relationship at IC25, IC50, IC75
and IC90. DRI indicates the magnitude of how the dose of each drug in a mixture can be reduced at
the given effect level compared to the doses of each drug alone. The dose–response analyses of toxin
mixtures, CI, and DRI were performed with Compusyn software (ComboSyn Inc., Paramus, NJ, USA).
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/10/12/526/
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Dose–response curves of (a) major A. sydowii metabolites, (b) dust storm/shellfish mycotoxins, and (c) algal
toxins on human neuroblastoma SH-SY5Y cells. Data are mean ± SD of four replicates. Figure S3: Okadaic acid
(OA), sydowinol (SYD), sydowinin A (SYDA), alamethicin (ALA), patulin (PAT), and gliotoxin (GLI) and their
binary mixture dose–responses for cytotoxicity against the human intestinal HT-29 cell line. Concentrations in
combinations were expressed as the sum of the concentrations of two toxins. Data are mean± SD of four replicates.
Figure S4: Okadaic acid (OA), sydowinol (SYD), sydowinin A (SYDA), alamethicin (ALA), patulin (PAT), and
gliotoxin (GLI) and their binary mixture dose–responses for cytotoxicity against the human neuroblastoma
SH-SY5Y cell line. Concentrations in combinations were expressed as the sum of the concentrations of two toxins.
Data are mean ± SD of four replicates.
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